
The many ways Kennedy is undermining vaccines
Get Starting Point
A guide through the most important stories of the morning, delivered Monday through Friday.
Enter Email
Sign Up
The Food and Drug Administration canceled an open meeting on flu vaccines with scientific advisers, later holding it behind closed doors. A top official paused the agency's review of Novavax's COVID-19 vaccine. In a televised interview last week, Kennedy said falsely that similarly created vaccines don't work against respiratory viruses.
Related
:
Advertisement
Some scientists said they saw a pattern: an effort to erode support for routine vaccination, and for the scientists who have long held it up as a public health goal.
'This is a simultaneous process of increasing the likelihood that you will hear his voice and decreasing the likelihood that you'll hear other voices,' Kathleen Hall Jamieson, director of the Annenberg Public Policy Center, said of Kennedy.
Advertisement
He is 'decertifying other voices of authority,' she said.
HHS disagreed that Kennedy was working against vaccines.
'Secretary Kennedy is not anti-vaccine; he is pro-safety,' Andrew Nixon, a department spokesperson said in a statement. 'His focus has always been on ensuring that vaccines are rigorously tested for efficacy and safety.'
The statement continued, 'We are taking action so that Americans get the transparency they deserve and can make informed decisions about their health.'
After attending the funeral of an unvaccinated child who died of measles in West Texas last Sunday, Kennedy endorsed the measles vaccine on the social platform X as 'the most effective way to prevent the spread of measles.'
But he has also described vaccination as a personal choice with poorly understood risks and suggested that miracle treatments were readily available. On Sunday, he praised two local doctors on social media who have promoted dubious, potentially harmful, treatments for measles.
Related
:
Even as cases of measles in the United States have surged past 600 in 22 jurisdictions, Kennedy has claimed in a recent interview that the measles vaccine causes deaths every year (untrue); that it causes encephalitis, blindness and 'all the illnesses that measles itself causes' (untrue); and that the vaccine's effect wanes so dramatically that older adults are 'essentially unvaccinated' (untrue).
According to an email obtained by The New York Times, HHS intends to revise its webpages to include statements like 'The decision to vaccinate is a personal one' and 'People should also be informed about the potential adverse events associated with vaccines.' (Vaccines are already administered only after patients provide informed consent, as required by law.)
Advertisement
Tensions with mainstream experts came into sharp focus last week, when Dr. Peter Marks, the top vaccine regulator, resigned under pressure from the FDA.
'It has become clear that truth and transparency are not desired by the secretary, but rather he wishes subservient confirmation of his misinformation and lies,' Marks said in his resignation letter.
Kennedy's position on vaccines has raised alarm for decades. But it has become particularly notable now, against a backdrop of rising skepticism of vaccines and worsening outbreaks of measles and bird flu, experts said.
The MMR vaccine -- a combination product to prevent measles, mumps and rubella that has been available since 1971 -- has long been a target of anti-vaccine campaigns because of the disproved theory that it can cause autism. Kennedy has said that he would like to revisit the issue, in part to assuage parents' fears that the vaccines are unsafe.
Related
:
But he has hired David Geier to reexamine the data. Sen. Bill Cassidy, R-La., a doctor and the chair of the Senate Health Committee, has sharply criticized the decision to spend tax dollars testing a discredited hypothesis even as the administration is cutting billions for other research.
'If we're pissing away money over here,' he said last month, 'that's less money that we have to actually go after the true reason.'
The refusal to accept scientific consensus is 'disturbing, because then we get into very strange territory where it's somebody's hunch that this does or doesn't happen, or does or doesn't work,' said Stephen Jameson, president of the American Association of Immunologists.
In interviews, Kennedy has downplayed risks of measles and emphasized what he sees as the benefits of infection.
Advertisement
'Everybody got measles, and measles gave you protected lifetime protection against measles infection -- the vaccine doesn't do that,' he said in an interview on Fox News.
Two doses of the MMR vaccine do provide decades-long immunity. And while immunity from the infection may last a lifetime, 'people also suffer the consequences of that natural infection,' Jameson said.
One consequence was discovered just a few years ago: A measles infection can destroy the immune system's memory of other invading pathogens, leaving the body vulnerable to them again.
Measles kills roughly 1 in every 1,000 infected people, and 11% of those infected this year have been hospitalized, many of them children younger than 5, according to the CDC. Two girls, ages 6 and 8, died in West Texas.
Related
:
By contrast, side effects after vaccination are uncommon. But Kennedy has suggested that people should apprise themselves of the risks before opting for the shot.
The phrasing implies that 'if you are more fully informed, you might make a different decision,' said Jamieson, of the Annenberg center.
Doctors have long expected health secretaries and the CDC to urge widespread vaccination unequivocally amid an outbreak, and in the past they have.
But Kennedy has spoken enthusiastically about cod liver oil, a steroid and an antibiotic that are not standard therapies. Some of those treatments may be making children more sick.
'The messaging I'm seeing is focused on potential treatments for measles,' said Dr. Sean O'Leary, chair of the infectious disease committee for the American Academy of Pediatrics.
Robert F. Kennedy Jr. spoke during his Senate confirmation hearing on Jan. 29.
KENNY HOLSTON/NYT
At his confirmation hearing, Kennedy promised that he would not change the CDC's childhood vaccination schedule. About two weeks later, he announced a new commission that would scrutinize it.
Advertisement
The schedule is based on recommendations from the Advisory Committee on Immunization Practices, a panel of medical experts who review safety and effectiveness data, potential interactions with other drugs and the ideal timing to maximize protection.
At his confirmation hearing, Kennedy claimed that 97% of ACIP members had financial conflicts of interest. He has long held, without evidence, that federal regulators are compromised and are hiding information about the risks of vaccines.
'It's frankly false,' said O'Leary, who serves as a liaison to the committee from the pediatric academy.
Kennedy's statistic came from a 2009 report that found that 97% of disclosure forms had errors, such as missing dates or information in the wrong section.
In fact, ACIP members are carefully screened for major conflicts of interest, and they cannot hold stocks or serve on advisory boards or speaker bureaus affiliated with vaccine manufacturers.
On the rare occasion that members have indirect conflicts of interest -- for example, if an institution at which they work receives money from a drug manufacturer -- they disclose the conflict and recuse themselves from related votes.
The committee's votes were public and often heavily debated.
'When I was CDC director, people flew in from Korea and all over the world to observe the ACIP meetings, because they were a model of transparency,' said Dr. Thomas R. Frieden, who led the agency from 2009 to 2017.
Kennedy has repeatedly promised greater transparency and accountability, but he has proposed ending public comment on health policies.
His department canceled a meeting of the ACIP in February at which members were set to discuss vaccines for meningitis and flu, rescheduling it for April.
Advertisement
The department also canceled a meeting to discuss the seasonal flu vaccine. Officials met later without the agency's scientific advisers.
'After all that conversation about how they want to be transparent, one of the first things he does is take things behind closed doors and diminish the amount of public input we're getting,' said Dr. Georges Benjamin, executive director of the American Public Health Association.
At his confirmation hearing, Kennedy repeated a fringe theory that Black Americans should not receive the same vaccines as others because they 'have a much stronger reaction.'
Sen. Angela Alsobrooks, D-Md., who is Black, admonished him for his 'dangerous' opinion: 'Your voice would be a voice that parents would listen to.'
Two weeks later, at a clinic for teenage mothers in Denver, a 19-year-old woman refused all vaccines for herself and her 1-year-old son -- including the measles and chickenpox shots he was supposed to have that day.
She told the pediatrician, Dr. Hana Smith, who described the incident, that she had read online that vaccines were bad for people with more melanin in their skin.
There are reams of evidence to the contrary. Still, it quickly became clear to Smith that nothing was going to change her patient's mind.
'No matter how much information I can give to the contrary on it, the damage is already done,' Smith said.
Misinformation is particularly difficult to counter, Smith said, 'when it's someone that has a leadership position, especially within the health care system.'
This article originally appeared in
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
an hour ago
- Time Business News
Next-Gen Mental Health Apps
A mental health app is a digital tool designed to support emotional welfare, stress, anxiety, depression, or other mental health conditions through mood tracking, directed therapy, attention, cognitive behavior technique and characteristics such as AI-operated chat support. Mental health app growth of market growth is inspired by increasing mental health awareness, increasing smartphone penetration, increasing demand for accessible and inexpensive mental health solutions and lack of mental health professionals. Additionally, the Covid-19 epidemics accelerated the adoption of digital health equipment, while innovations in AI, privatization and data analytics continue to promote user's busyness and market expansion. Key Growth Drivers and Opportunities Increasing Mental Health Awareness: Mental health awareness is a major driver of the mental health app market, as it encourages more people to seek help, reduce stigma and prioritize emotional welfare. Since individuals are informed more about the importance of mental health issues and early intervention, demand for mobile apps such as accessible, inexpensive and stigma-free solutions increases rapidly. These apps provide private, on-demand support for stress, anxiety, depression and self-care, which they appeal to broad audiences-especially in areas with limited access to traditional mental health services. This growing awareness fuel the user and fuel investment in new digital mental health equipment. Challenges The mental health app market has constraints such as the issue of data privacy and security amid the storing and processing of sensitive personal information. The fact-evidence is that most of these applications have never undergone clinical trials and, as a result, it is clearly not guaranteed that they will work for everyone, hence the question of their efficiency and safety. The reason behind this is that there is no proper authority for monitoring the activities of these platforms leading to quality disparities. As if that is not enough, there are social barriers such as the limited number of people who own smartphones, those without digital literacy, or people without a stable internet connection that hinder many others from accessing the apps. Innovation and Expansion Supportive Mind' App for Mental Wellness Launched by Infosys and Mental Health Foundation Australia In June 2025, the 'Supportive Mind' mobile app is the result of a strategic partnership between Infosys, a worldwide leader in next-generation digital services and consultancy, and Mental Health Foundation Australia (MHFA) to raise awareness of mental health issues. The goal of this Infosys-developed app for MHFA is to give communities and first responders in Australia and New Zealand instant access to mental health services. This program is a component of Infosys' commitment to corporate social responsibility, which aims to use technology to promote the welfare of communities. The application aims to provide practical answers for proactive self-care and assistance by filling in knowledge gaps on mental health. Magellan Health Releases Youth Support App for Mental Wellness In September 2024, in The Teen Mental Wellbeing app was released by Magellan Health, Inc., a pioneer in behavioral health and associated services, to promote the mental and emotional health of adolescents and young adults (ages 13 to 22). Through evidence-based practices and digital tools supported by research, the app promotes the road to mental wellbeing, fosters self-awareness, and increases resilience. It is powered by BeMe Health's cutting-edge digital health platform. With evidence-based tools and real-time human connection, the Teen Mental wellness app, powered by BeMe, is made to meet adolescents and young adults where they are on their phones in a fun and secure setting so they can take proactive measures to manage their wellness. Additionally, the app includes a number of scientifically recognized assessments, such as those for anxiety and depression, which can direct users to the best therapies for them. Inventive Sparks, Expanding Markets The key players operating the mental health app market includes, Addicaid, Silver Cloud Health Inc., Headspace Inc., Aurora health care, Happify Inc., 7 cups of tea, Mood Mission Pvt Ltd., Ustwo Fampany ltd., NOCD Inc., Talkspace, Sanvello Health Inc., Inc., Mindscape, Flow and Youper Inc., Recovery Record Inc., and others. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS


Time Business News
an hour ago
- Time Business News
N95 Masks and Growth Factors Boost Health and Healing
N95 Mask is a respiratory protective device manufactured to gain a very close facial fit and very effective filtration of airborne particles. National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), and Occupational Safety and Health Administration (OSHA) also regulate N95 respirators. Growth factors, naturally occurring proteins, play a key role through modulating cell growth, wound repair, and tissue renewal. In the context of gene therapy, they help encourage repair mechanisms and improve treatment results in cases involving wounds, bone problems, and heart issues. Their capacity to improve cell reactions makes them very important in both regenerative medicine and precise gene transfer methods. Key Growth Drivers and Opportunities Demand for N-95 mask: To meet the rising need for masks during the COVID-19 outbreak, many manufacturers are boosting their output and producing millions of N95 masks. The global increase in these illnesses means the N95 mask market is growing, pushing mask makers to increase production and better their market standing. For instance, Honeywell is rapidly ramping up production and making millions of the N95 masks in the U.S. They are expanding manufacturing operations in a factory in Rhode Island, Smithfield, which also produces UVEX safety glasses. Challenges The major challenge is people suffering from chronic respiratory, cardiac, or other medical conditions should contact their health care provider before using an N95 respirator because the N95 respirator may cause more difficulty in breathing for patients. The restrictive nature and filtering capabilities of masks may place extra stress on a person's breathing or heart function. Healthcare providers can evaluate these risks and suggest safer options or ways to use masks. Innovation and Expansion 3M and Honeywell Boost N95 Innovation for Healthcare Needs In February 2023, Honeywell has released a new series of N95 masks for healthcare professionals. 3M's investment of USD 1 billion shows its dedication to greatly increasing N95 mask output to meet expanding global needs. 3M has stated it will put USD 1 billion into its N95 mask production. Honeywell's N95 line introduced in February 2023 shows a focus on healthcare workers. The masks are designed for smaller faces and for comfort during long periods of usage. WHO Endorses N95 Masks to Shield Health Workers from COVID-19 In March 2023, the World Health Organization (WHO) recommended the use of N95 masks for healthcare workers treating patients with COVID-19. The recommendation was offered as the mask provides effective filtration, blocking at least 95% of particles in the air. The WHO said to use them in places where the risk is high, like ICUs, and when doing things that create aerosols. The point of the advice was to keep workers safe from germs in the air and lower how many people get sick in hospitals. Inventive Sparks, Expanding Markets The key players operating the global N-95 mask market includes 3M, Honeywell, Prestige Ameritech, Kimberly-Clark, Shanghai Dasheng, Vogmask, among others. Prestige Ameritech limited supplying mask production to countries globally. Te Yin and Shanghai Dasheng are some of the respirator producers from China. Cambridge Mask Co (UK) and DACH Schutzbekleidung GmbH (Germany) are some of the European mask manufacturers. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS


Boston Globe
an hour ago
- Boston Globe
The US fertility rate reached a new low in 2024, CDC data shows
Alarmed by recent drops, the Trump administration has taken steps to increase falling birth rates, like issuing an executive order meant to expand access to and reduce costs of in vitro fertilization and backing the idea of 'baby bonuses' that might encourage more couples to have kids. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up But there's no reason to be alarmed, according to Leslie Root, a University of Colorado Boulder researcher focused on fertility and population policy. Advertisement 'We're seeing this as part of an ongoing process of fertility delay. We know that the U.S. population is still growing, and we still have a natural increase — more births than deaths,' she said. The U.S. Centers for Disease Control and Prevention released the statistic for the total fertility rate with updated birth data for 2024. In the early 1960s, the U.S. total fertility rate was around 3.5, but plummeted to 1.7 by 1976 after the Baby Boom ended. It gradually rose to 2.1 in 2007 before falling again, aside from a 2014 uptick. The rate in 2023 was 1.621, and inched down in 2024 to 1.599, according to the CDC's National Center for Health Statistics. Advertisement Birth rates are generally declining for women in most age groups — and that doesn't seem likely to change in the near future, said Karen Guzzo, director of the Carolina Population Center at the University of North Carolina. People are marrying later and also worried about their ability to have the money, health insurance and other resources needed to raise children in a stable environment. 'Worry is not a good moment to have kids,' and that's why birth rates in most age groups are not improving, she said. Asked about birth-promoting measures outlined by the Trump administration, Guzzo said they don't tackle larger needs like parental leave and affordable child care. 'The things that they are doing are really symbolic and not likely to budge things for real Americans,' she said. Increase in births in new data The CDC's new report, which is based on a more complete review of birth certificates than provisional data released earlier this year, also showed a 1% increase in births — about 33,000 more — last year compared to the prior year. That brought the yearly national total to just over 3.6 million babies born. But this is different: The provisional data indicated birth rate increases last year for women in their late 20s and 30s. However, the new report found birth rate declines for women in their 20s and early 30s, and no change for women in their late 30s. What happened? CDC officials said it was due to recalculations stemming from a change in the U.S. Census population estimates used to compute the birth rate. Advertisement That's plausible, Root said. As the total population of women of childbearing age grew due to immigration, it offset small increases in births to women in those age groups, she said.